Loading clinical trials...

Safety and Efficacy of a Phased Transition From Epogen to Three Times Weekly Oral Vadadustat for the Treatment of Anemia in Subjects Receiving In-Center Hemodialysis | Clinical Trials | Clareo Health

Back to clinical trial search

Not Yet RecruitingPhase 3NCT07565701

Safety and Efficacy of a Phased Transition From Epogen to Three Times Weekly Oral Vadadustat for the Treatment of Anemia in Subjects Receiving In-Center Hemodialysis

The goal of this study is to assess if patients can be retained on long-term vadadustat therapy (and thus potentially benefit from the favorable safety profile) by incorporating a phased transition fr...

Lead sponsor: Geoff Block•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Stephanie Brillhart

CONTACT

13038819451 [email protected]

Martha Block

CONTACT

[email protected]

Related studies

WITHDRAWNPhase 3

Investigating the Efficacy, Safety and PK of Roxadustat (FG-4592) for Treatment of Anemia in Pediatric Patients With CKD

NCT04621331 · Anemia Associated With Chronic Kidney Disease

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 4, 2026Terms

Trial snapshot

StatusNOT_YET_RECRUITING

PhasePHASE3

Enrollment100

Start dateApr 2026

Last updatedMay 4, 2026

Condition

Anemia Associated With Chronic Kidney Disease

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 4, 2026Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions